Canonical ingredient
4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-
ALLOPURINOL
48 linked products
Official identifiers
Names and synonyms
- 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro- (en)
- Allopurinol (fr)
- Allopurinol (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- allopurinol
GLOBAL · CAS 315-30-0
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
AG-ALLOPURINOL
100 · MG
AG-ALLOPURINOL
200 · MG
AG-ALLOPURINOL
300 · MG
ALLOPRIN
100 · MG
ALLOPRIN
300 · MG
ALLOPRIN
200 · MG
ALLOPURINOL
300 · MG
ALLOPURINOL TABLETS 100MG
100 · MG
ALLOPURINOL TABLETS 200MG
200 · MG
ALLOPURINOL TABLETS 300MG
300 · MG
ALLOPURINOL-100
100 · MG
ALLOPURINOL-200
200 · MG
ALLOPURINOL-300
300 · MG
APO-ALLOPURINOL
100 · MG
APO-ALLOPURINOL
200 · MG
APO-ALLOPURINOL
300 · MG
APO-ALLOPURINOL TABLETS
300 · MG
APO-ALLOPURINOL TABLETS
100 · MG
APO-ALLOPURINOL TABLETS
200 · MG
IPG-ALLOPURINOL
100 · MG
IPG-ALLOPURINOL
200 · MG
IPG-ALLOPURINOL
300 · MG
JAMP ALLOPURINOL
100 · MG
JAMP ALLOPURINOL
200 · MG
JAMP ALLOPURINOL
300 · MG
JAMP ALLOPURINOL TABLETS
100 · MG
JAMP ALLOPURINOL TABLETS
200 · MG
JAMP ALLOPURINOL TABLETS
300 · MG
MAR-ALLOPURINOL
100 · MG
MAR-ALLOPURINOL
200 · MG
MAR-ALLOPURINOL
300 · MG
NOVO-PUROL TAB 100MG
100 · MG
NOVO-PUROL TAB 200 MG
200 · MG
NOVO-PUROL TAB 300MG
300 · MG
NTP-ALLOPURINOL
100 · MG
NTP-ALLOPURINOL
200 · MG
NTP-ALLOPURINOL
300 · MG
PMS-ALLOPURINOL
100 · MG
PMS-ALLOPURINOL
300 · MG
PMS-ALLOPURINOL
200 · MG
PURINOL TAB 100MG
100 · MG
PURINOL TAB 200MG
200 · MG
PURINOL TAB 300MG
300 · MG
RIVA-PURINOL 100MG TABLETS
100 · MG
RIVA-PURINOL 200MG TABLETS
200 · MG
RIVA-PURINOL 300MG TABLETS
300 · MG
ZYLOPRIM 100
100 · MG
ZYLOPRIM 200
200 · MG